Vice President, Investments
Young joined Tuatara Capital’s investment team in April 2017. Young is responsible for the identification and analyses of new investment opportunities, leading due diligence and execution of new investments, leading and assisting with portfolio company monitoring, and tracking and analyzing cannabis industry trends.
Prior to joining Tuatara, Young was an Associate at China Momentum Fund, L.P., a $1.1 billion private equity fund managed by Fosun International, one of China’s largest investment conglomerates with over $80 billion in assets under management. In that role, Young was responsible for analyzing and executing North American private equity investments across a broad spectrum of industries including consumer retail, media & entertainment, travel & hospitality, and food & beverage. Young began his career as a scientist at Carnegie Mellon University, where he conducted research in biochemistry and genetic engineering, and he also worked in pharmaceutical vaccine production at Merck & Co., an international developer, manufacturer and distributor of pharmaceuticals.
Young earned a B.S. in Chemistry from Carnegie Mellon University, where he was on the Dean’s List with High Honors and was one of two students that graduated with the Mellon College of Science Departmental Honors for excellence in scientific research. In his free time, Young enjoys basketball and piano.